Company Overview of Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. develops therapies for the treatment of neuro-inflammatory diseases. The company offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded in 2009 and is based in San Francisco, California.
30 Hill Street
San Francisco, CA 94110
Founded in 2009
Key Executives for Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Longevity Biotech, Inc.||United States|
|ALTATHERA Pharmaceuticals, LLC||United States|
|Adolor Corporation||United States|
|TargeGen Inc.||United States|
|Epiphany Biosciences, Inc.||United States|
Recent Private Companies Transactions
June 25, 2015
To contact Xalud Therapeutics, Inc., please visit www.xaludthera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.